Epoprostenol treatment of acute pulmonary hypertension is associated with a paradoxical decrease in right ventricular contractility

Intensive Care Medicine

Volumn 34, Issue 1, 2008, Pages 179-189

  Rex, Steffen ^b,c   Missant, Carlo ^b   Segers, Patrick ^d   Rossaint, Rolf ^c   Wouters, Patrick F ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Epoprostenol; Hemodynamic processes; Hypertension; Myocardial contraction; Pulmonary

Indexed keywords

PROSTACYCLIN;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG DOSE COMPARISON; HEART AFTERLOAD; HEART CONTRACTION; HEART DISEASE; HEART PRELOAD; HEART RIGHT VENTRICLE; HEART STROKE VOLUME; HEART VENTRICLE CONTRACTILITY; HYPOXIA; INOTROPISM; LUNG PRESSURE; NONHUMAN; PULMONARY ARTERY; PULMONARY HYPERTENSION; SWINE; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ACUTE DISEASE; ANIMALS; ANTIHYPERTENSIVE AGENTS; EPOPROSTENOL; HEMODYNAMICS; HYPERTENSION, PULMONARY; MYOCARDIAL CONTRACTION; SWINE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 38149026128     PISSN: 03424642     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00134-007-0831-8     Document Type: Article

References (47)

1. Monchi M, Bellenfant F, Cariou A, Joly LM, Thebert D, Laurent I, Dhainaut JF, Brunet F (1998) Early predictive factors of survival in the acute respiratory distress syndrome. A multivariate analysis. Am J Respir Crit Care Med 158:1076-1081
2. Davila-Roman VG, Waggoner AD, Hopkins WE, Barzilai B (1995) Right ventricular dysfunction in low output syndrome after cardiac operations: assessment by transesophageal echocardiography. Ann Thorac Surg 60:1081-1086
3. D'Alonzo GE, Barst RJ, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Kernis JT (1991) Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. Ann Intern Med 115:343-349
4. Graham TP Jr, Bernard YD, Mellen BG, Celermajer D, Baumgartner H, Cetta F, Connolly HM, Davidson WR, Dellborg M, Foster E, Gersony WM, Gessner IH, Hurwitz RA, Kaemmerer H, Kugler JD, Murphy DJ, Noonan JA, Morris C, Perloff JK, Sanders SP, Sutherland JL (2000) Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol 36:255-261
5. Hinderliter AL, Willis PW, Barst RJ, Rich S, Rubin LJ, Badesch DB, Groves BM, McGoon MD, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Koch G, Li S, Clayton LM, Jobsis MM, Blackburn SD Jr, Crow JW, Long WA (1997) Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation 95:1479-1486
6. McLaughlin VV, Genthner DE, Panella MM, Rich S (1998) Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 338:273-277
7. Lowson SM (2002) Inhaled alternatives to nitric oxide. Anesthesiology 96:1504-1513
8. Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 334:296-302
9. Olschewski H, Rose F, Schermuly R, Ghofrani HA, Enke B, Olschewski A, Seeger W (2004) Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther 102:139-153
10. Kisch-Wedel H, Kemming G, Meisner F, Flondor M, Kuebler WM, Bruhn S, Koehler C, Zwissler B (2003) The prostaglandins epoprostenol and iloprost increase left ventricular contractility in vivo. Intensive Care Med 29:1574-1583
11. Montalescot G, Drobinski G, Meurin P, Maclouf J, Sotirov I, Philippe F, Choussat R, Morin E, Thomas D (1998) Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol 82:749-755
12. Fassina G, Tessari F, Dorigo P (1983) Positive inotropic effect of a stable analogue of PGI2 and of PGI2 on isolated guinea pig atria. Mechanism of action. Pharmacol Res Commun 15:735-749
13. Pavlovic M, Petkovic D, Cvetkovic M, Macut DJ, Zdjelar K, Nesic M, Bosnic O, Radulovic R, Mihajlovic M (1995) The influence of prostacyclin (PGI2) on contractile properties of isolated right ventricle of rat heart. Experientia 51:941-944
14. Rimoldi O, Pierini S, Pagani MR, Pagani M (1991) Reduced cardiovascular sympathetic excitatory responses during iloprost infusion in conscious dogs. Cardiovasc Res 25:793-801
15. Malik KU, Sehic E (1990) Prostaglandins and the release of the adrenergic transmitter. Ann N Y Acad Sci 604:222-236
16. Panzenbeck MJ, Tan W, Hajdu MA, Zucker IH (1988) Intracoronary infusion of prostaglandin I2 attenuates arterial baroreflex control of heart rate in conscious dogs. Circ Res 63:860-868
17. Lanier SM, Malik KU (1985) Inhibition by prostaglandins of adrenergic transmission in the left ventricular myocardium of anesthetized dogs. J Cardiovasc Pharmacol 7:653-659
18. Kisch-Wedel H, Kemming G, Meisner F, Flondor M, Bruhn S, Koehler C, Messmer K, Zwissler B (2005) Effect of prostaglandin I2 analogues on left ventricular diastolic function in vivo. Eur J Pharmacol 517:208-216
19. Baan J, van der Velde ET, de Bruin HG, Smeenk GJ, Koops J, van Dijk AD, Temmerman D, Senden J, Buis B (1984) Continuous measurement of left ventricular volume in animals and humans by conductance catheter. Circulation 70:812-823
20. Steendijk P, Staal E, Jukema JW, Baan J (2001) Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter. Am J Physiol Heart Circ Physiol 281:H755-H763
21. Dickstein ML, Yano O, Spotnitz HM, Burkhoff D (1995) Assessment of right ventricular contractile state with the conductance catheter technique in the pig. Cardiovasc Res 29:820-826
22. Karunanithi MK, Michniewicz J, Copeland SE, Feneley MP (1992) Right ventricular preload recruitable stroke work, end-systolic pressure-volume, and dP/dtmax-end-diastolic volume relations compared as indexes of right ventricular contractile performance in conscious dogs. Circ Res 70:1169-1179
23. Burkhoff D, Mirsky I, Suga H (2005) Assessment of systolic and diastolic ventricular properties via pressure-volume analysis: a guide for clinical, translational, and basic researchers. Am J Physiol Heart Circ Physiol 289:H501-H512
24. Vroomen M de, Steendijk P, Lopes Cardozo RH, Brouwers HH, van Bel F, Baan J (2001) Enhanced systolic function of the right ventricle during respiratory distress syndrome in newborn lambs. Am J Physiol Heart Circ Physiol 280:H392-H400
25. Hettrick DA, Warltier DC (1995) Ventriculoarterial Coupling. 1:153-180
26. Brimioulle S, Maggiorini M, Stephanazzi J, Vermeulen F, Lejeune P, Naeije R (1999) Effects of low flow on pulmonary vascular flow-pressure curves and pulmonary vascular impedance. Cardiovasc Res 42:183-192
27. Rex S, Missant C, Segers P, Wouters PF (2007) Thoracic epidural anesthesia impairs the hemodynamic response to acute pulmonary hypertension by deteriorating right ventricular-pulmonary arterial coupling. Crit Care Med 35:222-229
28. Leeuwenburgh BP, Steendijk P, Helbing WA, Baan J (2002) Indexes of diastolic RV function: load dependence and changes after chronic RV pressure overload in lambs. Am J Physiol Heart Circ Physiol 282:H1350-H1358
29. Huez S, Retailleau K, Unger P, Pavelescu A, Vachiery JL, Derumeaux G, Naeije R (2005) Right and left ventricular adaptation to hypoxia: a tissue Doppler imaging study. Am J Physiol Heart Circ Physiol 289:H1391-H1398
30. Ludbrook J (1994) Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc Res 28:303-311
31. Ludbrook J (1998) Multiple comparison procedures updated. Clin Exp Pharmacol Physiol 25:1032-1037
32. Wauthy P, Pagnamenta A, Vassalli F, Naeije R, Brimioulle S (2004) Right ventricular adaptation to pulmonary hypertension: an interspecies comparison. Am J Physiol Heart Circ Physiol 286:H1441-H1447
33. Gaynor SL, Maniar HS, Bloch JB, Steendijk P, Moon MR (2005) Right atrial and ventricular adaptation to chronic right ventricular pressure overload. Circulation 112:I212-I218
34. Sarnoff SJ, Mitchell JH, Gilmore JP, Remensnyder JP (1960) Homeometric autoregulation in the heart. Circ Res 8:1077-1091
35. Wauthy P, Abdel KS, Mooi WJ, Naeije R, Brimioulle S (2003) Inhaled nitric oxide versus prostacyclin in chronic shunt-induced pulmonary hypertension. J Thorac Cardiovasc Surg 126:1434-1441
36. Segers P, Stergiopulos N, Westerhof N (2002) Relation of effective arterial elastance to arterial system properties. Am J Physiol Heart Circ Physiol 282:H1041-H1046
37. Naeije R (2003) Pulmonary vascular resistance. A meaningless variable? Intensive Care Med 29:526-529
38. Murray PA, Lodato RF, Michael JR (1986) Neural antagonists modulate pulmonary vascular pressure-flow plots in conscious dogs. J Appl Physiol 60:1900-1907
39. Auclair MC, Vernimmen C, Lechat P (1988) Influence of prostacyclin and two metabolites on the contractility of cultured rat heart cells. Prostaglandins Leukot Essent Fatty Acids 32:33-38
40. Lawler OA, Miggin SM, Kinsella BT (2001) Protein kinase A-mediated phosphorylation of serine 357 of the mouse prostacyclin receptor regulates its coupling to G(s)-, to G(i)-, and to G(q)-coupled effector signaling. J Biol Chem 276:33596-33607
41. Nilius SM, Hasse A, Kuger P, Schror K, Meyer-Kirchrath J (2000) Agonist-induced long-term desensitization of the human prostacyclin receptor. FEBS Lett 484:211-216
42. Panzenbeck MJ, Hintze TH, Kaley G (1988) 6-Keto-prostaglandin E1 is a potent coronary vasodilator and stimulates a vagal reflex in dogs. J Pharmacol Exp Ther 244:814-819
43. Galie N, Torbicki A, Barst R, Dartevelle P, Haworth S, Higenbottam T, Olschewski H, Peacock A, Pietra G, Rubin LJ, Simonneau G, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie M, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, McGregor K, Morais J, Oto A, Smiseth OA, Barbera JA, Gibbs S, Hoeper M, Humbert M, Naeije R, Pepke-Zaba J (2004) Guidelines on diagnosis and treatment of pulmonary arterial hypertension. The Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Eur Heart J 25:2243-2278
44. Ricksten SE (2003) Is prostacyclin an inodilator? Intensive Care Med 29:1403-1405
45. Teerlink JR (2005) Overview of randomized clinical trials in acute heart failure syndromes. Am J Cardiol 96:59G-67G
46. Kerbaul F, Brimioulle S, Rondelet B, Dewachter C, Hubloue I, Naeije R (2007) How prostacyclin improves cardiac output in right heart failure in conjunction with pulmonary hypertension. Am J Respir Crit Care Med 175:846-850
47. Guth BD, Schulz R, Heusch G (1991) Pressure-flow characteristics in the right and left ventricular perfusion territories of the right coronary artery in swine. Pflugers Arch 419:622-628